TL;DR
Bayer AG announced on May 6, 2026, its acquisition of Perfuse Therapeutics for up to $2.45 billion, including a $300 million upfront payment and $2.15 billion in milestones. The deal secures...
TL;DR
Brussels-based biopharma UCB will acquire Candid Therapeutics for up to $2.2 billion, comprised of a $2.0 billion upfront cash payment and $200 million in milestones. The deal centers on...
TL;DR
Mumbai-based Sun Pharmaceutical Industries Ltd. is finalizing a binding $12 billion offer for Organon & Co., marking the largest overseas acquisition in Indian pharma history. The deal is...
TL;DR
Merck & Co. has launched a $6.7 billion all-cash unsolicited offer for Terns Pharma, a biotech firm specializing in small-molecule drug candidates for metabolic disorders like NASH. The...
TL;DR
Alcon terminated its agreement to acquire Lensar for up to $430 million on March 17, 2026, citing a protracted, year-long regulatory review by the Federal Trade Commission (FTC). The FTC...
TL;DR
Medtronic announced a definitive agreement on March 10, 2026, to acquire Scientia Vascular for approximately $550 million. The deal targets Scientia's advanced guidewires and catheters,...
TL;DR
Agilent Technologies has agreed to acquire Biocare Medical for $950 million in an all-cash transaction, providing an exit for private equity sponsors Excellere Partners and GHO Capital....
TL;DR
Servier announced the acquisition of Day One Biopharmaceuticals for approximately $2.5 billion in an all-cash transaction on March 6, 2026. The deal, valued at $21.50 per share, represents a...
Paris-headquartered pharmaceutical giant Sanofi has agreed to divest its Brazilian generics unit, Medley, to local drugmaker EMS, in a move signaling further streamlining of its global portfolio and...
TL;DR
Novo Nordisk entered a partnership with Vivtex Corp. valued at up to $2.1 billion to develop oral medicines for obesity and diabetes. The deal leverages Vivtex's proprietary drug delivery...
